Helicobacter pylori stimulates epithelial cell migration via CagA-mediated perturbation of host cell signaling

Microbes and Infection

Volumn 14, Issue 5, 2012, Pages 470-476

  Kikuchi, Kenji ^a,b   Murata Kamiya, Naoko ^a   Kondo, Satoshi ^b   Hatakeyama, Masanori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CagA; Cell motility; Helicobacter pylori; PAR1 MARK; SHP2

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; PARTITIONING DEFECTIVE 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EPITHELIUM CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PATHOGENICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN MULTIMERIZATION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; CELL MOVEMENT; EPITHELIAL CELLS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; VIRULENCE FACTORS;

HELICOBACTER PYLORI;

EID: 84859434674     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.12.003     Document Type: Article

References (18)

1. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002, 2:28-37.
2. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 2004, 4:688-694.
3. Backert S., Ziska E., Brinkmann V., Zimny-Arndt U., Fauconnier A., Jungblut P.R., Naumann M., Meyer T.F. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol. 2000, 2:155-164.
4. Odenbreit S., Püls J., Sedlmaier B., Gerland E., Fischer W., Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000, 287:1497-1500.
5. Murata-Kamiya N., Kikuchi K., Hayashi T., Higashi H., Hatakeyama M. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 2010, 7:399-411.
6. Backert S., Feller S.M., Wessler S. Emerging roles of Abl family tyrosine kinases in microbial pathogenesis. Trends Biochem. Sci. 2008, 33:80-90.
7. Higashi H., Tsutsumi R., Muto S., Sugiyama T., Azuma T., Asaka M., Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002, 295:683-686.
8. Higashi H., Nakaya A., Tsutsumi R., Yokoyama K., Fujii Y., Ishikawa S., Higuchi M., Takahashi A., Kurashima Y., Teishikata Y., Tanaka S., Azuma T., Hatakeyama M. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 2004, 279:17205-17216.
9. Tsutsumi R., Takahashi A., Azuma T., Higashi H., Hatakeyama M. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol. Cell. Biol. 2006, 26:261-276.
10. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H., Ohnishi N., Azuma T., Suzuki A., Ohno S., Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007, 447:330-333.
11. Haas R., Meyer T.F., van Putten J.P. Aflagellated mutants of Helicobacter pylori generated by genetic transformation of naturally competent strains using transposon shuttle mutagenesis. Mol. Microbiol. 1993, 8:753-760.
12. Kurashima Y., Murata-Kamiya N., Kikuchi K., Higashi H., Azuma T., Kondo S., Hatakeyama M. Deregulation of β-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int. J. Cancer 2008, 122:823-831.
13. Ren S., Higashi H., Lu H., Azuma T., Hatakeyama M. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J. Biol. Chem. 2006, 281:32344-32352.
14. Cover T.L., Blanke S.R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 2005, 3:320-332.
15. Kim L.C., Song L., Haura E.B. Src kinases as therapeutic targets for cancer. Nat. Rev. Clin. Oncol. 2009, 6:587-595.
16. Ohnishi N., Yuasa H., Tanaka S., Sawa H., Miura M., Matsui A., Higashi H., Musashi M., Iwabuchi K., Suzuki M., Yamada G., Azuma T., Hatakeyama M. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. USA 2008, 105:1003-1008.
17. Araki T., Mohi M.G., Ismat F.A., Bronson R.T., Williams I.R., Kutok J.L., Yang W., Pao L.I., Gilliland D.G., Epstein J.A., Neel B.G. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat. Med. 2004, 10:849-857.
18. Nagy T.A., Frey M.R., Yan F., Israel D.A., Polk D.B., Peek R.M. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J. Infect. Dis. 2009, 199:641-651.